市場調査レポート

商品コード

1530949

インターロイキン市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Interleukins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日: 2024年06月24日
発行: Transparency Market Research
ページ情報: 英文 147 Pages
納期: 2～10営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 5,795 850,821円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Multi-user License)

USD 8,795 1,291,281円

レポートPDFを同一の部署内・課内の5名の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

PDF (Corporate License)

USD 11,795 1,731,741円

レポートPDFを企業内すべての方に使用頂けるライセンスです。ご利用人数の制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は可能です。印刷物の取り扱いは電子版のライセンス範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

インターロイキン市場- 調査範囲

TMRの調査レポート「インターロイキンの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のインターロイキン市場の収益と予測を提供しています。また、2024年から2034年までの世界のインターロイキン市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、インターロイキン市場を推察しました。

市場スナップショット
2023年の市場規模	429億米ドル
2034年の市場規模	2,186億米ドル
CAGR	15.9%

本レポートでは、世界のインターロイキン市場の競合情勢について掘り下げています。世界のインターロイキン市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界のインターロイキン市場におけるプレイヤーの属性です。

市場企業- 競争マトリックス（企業階層と規模別）
市場シェア分析：企業別（2023年）
企業プロファイル
- Novartis AG
- AbbVie Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Regeneron Pharmaceuticals, Inc.
- Johnson & Johnson
- AstraZeneca plc
- Bausch Health
- GSK plc
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.

図表

List of Tables

Table 01: Global Interleukins Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 02: Global Interleukins Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 03: Global Interleukins Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 04: Global Interleukins Market Size (US$ Bn) Forecast, by Region, 2020-2034
Table 05: North America Interleukins Market Size (US$ Bn) Forecast, by Country, 2020-2034
Table 06: North America Interleukins Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 07: North America Interleukins Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 08: North America Interleukins Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 09: Europe Interleukins Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Interleukins Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 11: Europe Interleukins Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 12: Europe Interleukins Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 13: Asia Pacific Interleukins Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Interleukins Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 15: Asia Pacific Interleukins Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 16: Asia Pacific Interleukins Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 17: Latin America Interleukins Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Interleukins Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 19: Latin America Interleukins Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 20: Latin America Interleukins Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
Table 21: Middle East & Africa Interleukins Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Interleukins Market Size (US$ Bn) Forecast, by Type, 2020-2034
Table 23: Middle East & Africa Interleukins Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
Table 24: Middle East & Africa Interleukins Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

Figure 01: Global Interleukins Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Interleukins Market Revenue (US$ Bn), by Type, 2023
Figure 03: Global Interleukins Market Value Share, by Type, 2023
Figure 04: Global Interleukins Market Revenue (US$ Bn), by Disease Indication, 2023
Figure 05: Global Interleukins Market Value Share, by Disease Indication, 2023
Figure 06: Global Interleukins Market Revenue (US$ Bn), by Distribution Channel, 2023
Figure 07: Global Interleukins Market Value Share, by Distribution Channel, 2023
Figure 08: Global Interleukins Market Value Share, by Region, 2023
Figure 09: Global Interleukins Market Value (US$ Bn) Forecast, 2020-2034
Figure 10: Global Interleukins Market Value Share Analysis, by Type, 2023 and 2034
Figure 11: Global Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Interleukins Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 13: Global Interleukins Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 14: Global Interleukins Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 15: Global Interleukins Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 16: Global Interleukins Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Interleukins Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Interleukins Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Interleukins Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Interleukins Market Value Share Analysis, by Type, 2023 and 2034
Figure 22: North America Interleukins Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 23: North America Interleukins Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 24: North America Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Interleukins Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 26: North America Interleukins Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 27: Europe Interleukins Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Interleukins Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Interleukins Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Interleukins Market Value Share Analysis, by Type, 2023 and 2034
Figure 31: Europe Interleukins Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 32: Europe Interleukins Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 33: Europe Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Interleukins Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 35: Europe Interleukins Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 36: Asia Pacific Interleukins Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Interleukins Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Interleukins Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Interleukins Market Value Share Analysis, by Type, 2023 and 2034
Figure 40: Asia Pacific Interleukins Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 41: Asia Pacific Interleukins Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 42: Asia Pacific Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Interleukins Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 44: Asia Pacific Interleukins Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 45: Latin America Interleukins Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Interleukins Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Interleukins Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Interleukins Market Value Share Analysis, by Type, 2023 and 2034
Figure 49: Latin America Interleukins Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 50: Latin America Interleukins Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 51: Latin America Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Interleukins Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 53: Latin America Interleukins Market Attractiveness Analysis, by Distribution Channel, 2024-2034
Figure 54: Middle East & Africa Interleukins Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Interleukins Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Interleukins Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Interleukins Market Value Share Analysis, by Type, 2023 and 2034
Figure 58: Middle East & Africa Interleukins Market Value Share Analysis, by Disease Indication, 2023 and 2034
Figure 59: Middle East & Africa Interleukins Market Value Share Analysis, by Distribution Channel, 2023 and 2034
Figure 60: Middle East & Africa Interleukins Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Interleukins Market Attractiveness Analysis, by Disease Indication, 2024-2034
Figure 62: Middle East & Africa Interleukins Market Attractiveness Analysis, by Distribution Channel, 2024-2034

Product Code: TMRGL86243

Interleukins Market - Scope of Report

TMR's report on the global interleukins market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global interleukins market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global interleukins market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the interleukins market.

Market Snapshot
Market Value in 2023	US$ 42.9 Bn
Market Value in 2034	US$ 218.6 Bn
CAGR	15.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global interleukins market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global interleukins market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global interleukins market.

The report delves into the competitive landscape of the global interleukins market. Key players operating in the global interleukins market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global interleukins market profiled in this report.

Key Questions Answered in Global interleukins Market Report:

What is the sales/revenue generated by interleukins across all regions during the forecast period?
What are the opportunities in the global interleukins market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Interleukins Market - Research Objectives and Research Approach

The comprehensive report on the global interleukins market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global interleukins market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global interleukins market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Interleukins Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Interleukins Market Analysis and Forecast, 2020-2034

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Interleukins Market Analysis and Forecast, by Type

6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
- 6.3.1. IL-1
- 6.3.2. IL-5
- 6.3.3. IL-6
- 6.3.4. IL-23
- 6.3.5. Others (IL-23, etc.)
6.4. Market Attractiveness Analysis, by Type

7. Global Interleukins Market Analysis and Forecast, by Disease Indication

7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2020-2034
- 7.3.1. Psoriasis
- 7.3.2. Psoriatic Arthritis
- 7.3.3. Inflammatory Bowel Disease
- 7.3.4. Ankylosing Spondylitis
- 7.3.5. Eczema
- 7.3.6. Gout
- 7.3.7. Others (Systematic Sclerosis, etc.)
7.4. Market Attractiveness Analysis, by Disease Indication

8. Global Interleukins Market Analysis and Forecast, by Distribution Channel

8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
- 8.3.1. Hospital Pharmacies
- 8.3.2. Online Pharmacies
- 8.3.3. Retail Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Interleukins Market Analysis and Forecast, by Region

9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Interleukins Market Analysis and Forecast

10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Type, 2020-2034
- 10.3.1. IL-1
- 10.3.2. IL-5
- 10.3.3. IL-6
- 10.3.4. IL-23
- 10.3.5. Others (IL-23, etc.)
10.4. Market Value Forecast, by Disease Indication, 2020-2034
- 10.4.1. Psoriasis
- 10.4.2. Psoriatic Arthritis
- 10.4.3. Inflammatory Bowel Disease
- 10.4.4. Ankylosing Spondylitis
- 10.4.5. Eczema
- 10.4.6. Gout
- 10.4.7. Others (Systematic Sclerosis, etc.)
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
- 10.5.1. Hospital Pharmacies
- 10.5.2. Online Pharmacies
- 10.5.3. Retail Pharmacies
10.6. Market Value Forecast, by Country, 2020-2034
- 10.6.1. U.S.
- 10.6.2. Canada
10.7. Market Attractiveness Analysis
- 10.7.1. By Type
- 10.7.2. By Disease Indication
- 10.7.3. By Distribution Channel
- 10.7.4. By Country

11. Europe Interleukins Market Analysis and Forecast

11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Type, 2020-2034
- 11.3.1. IL-1
- 11.3.2. IL-5
- 11.3.3. IL-6
- 11.3.4. IL-23
- 11.3.5. Others (IL-23, etc.)
11.4. Market Value Forecast, by Disease Indication, 2020-2034
- 11.4.1. Psoriasis
- 11.4.2. Psoriatic Arthritis
- 11.4.3. Inflammatory Bowel Disease
- 11.4.4. Ankylosing Spondylitis
- 11.4.5. Eczema
- 11.4.6. Gout
- 11.4.7. Others (Systematic Sclerosis, etc.)
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
- 11.5.1. Hospital Pharmacies
- 11.5.2. Online Pharmacies
- 11.5.3. Retail Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 11.6.1. Germany
- 11.6.2. U.K.
- 11.6.3. France
- 11.6.4. Italy
- 11.6.5. Spain
- 11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
- 11.7.1. By Type
- 11.7.2. By Disease Indication
- 11.7.3. By Distribution Channel
- 11.7.4. By Country/Sub-region

12. Asia Pacific Interleukins Market Analysis and Forecast

12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Type, 2020-2034
- 12.3.1. IL-1
- 12.3.2. IL-5
- 12.3.3. IL-6
- 12.3.4. IL-23
- 12.3.5. Others (IL-23, etc.)
12.4. Market Value Forecast, by Disease Indication, 2020-2034
- 12.4.1. Psoriasis
- 12.4.2. Psoriatic Arthritis
- 12.4.3. Inflammatory Bowel Disease
- 12.4.4. Ankylosing Spondylitis
- 12.4.5. Eczema
- 12.4.6. Gout
- 12.4.7. Others (Systematic Sclerosis, etc.)
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
- 12.5.1. Hospital Pharmacies
- 12.5.2. Online Pharmacies
- 12.5.3. Retail Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 12.6.1. China
- 12.6.2. Japan
- 12.6.3. India
- 12.6.4. Australia & New Zealand
- 12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
- 12.7.1. By Type
- 12.7.2. By Disease Indication
- 12.7.3. By Distribution Channel
- 12.7.4. By Country/Sub-region

13. Latin America Interleukins Market Analysis and Forecast

13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Type, 2020-2034
- 13.3.1. IL-1
- 13.3.2. IL-5
- 13.3.3. IL-6
- 13.3.4. IL-23
- 13.3.5. Others (IL-23, etc.)
13.4. Market Value Forecast, by Disease Indication, 2020-2034
- 13.4.1. Psoriasis
- 13.4.2. Psoriatic Arthritis
- 13.4.3. Inflammatory Bowel Disease
- 13.4.4. Ankylosing Spondylitis
- 13.4.5. Eczema
- 13.4.6. Gout
- 13.4.7. Others (Systematic Sclerosis, etc.)
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
- 13.5.1. Hospital Pharmacies
- 13.5.2. Online Pharmacies
- 13.5.3. Retail Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 13.6.1. Brazil
- 13.6.2. Mexico
- 13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
- 13.7.1. By Type
- 13.7.2. By Disease Indication
- 13.7.3. By Distribution Channel
- 13.7.4. By Country/Sub-region

14. Middle East & Africa Interleukins Market Analysis and Forecast

14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Type, 2020-2034
- 14.3.1. IL-1
- 14.3.2. IL-5
- 14.3.3. IL-6
- 14.3.4. IL-23
- 14.3.5. Others (IL-23, etc.)
14.4. Market Value Forecast, by Disease Indication, 2020-2034
- 14.4.1. Psoriasis
- 14.4.2. Psoriatic Arthritis
- 14.4.3. Inflammatory Bowel Disease
- 14.4.4. Ankylosing Spondylitis
- 14.4.5. Eczema
- 14.4.6. Gout
- 14.4.7. Others (Systematic Sclerosis, etc.)
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
- 14.5.1. Hospital Pharmacies
- 14.5.2. Online Pharmacies
- 14.5.3. Retail Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
- 14.6.1. GCC Countries
- 14.6.2. South Africa
- 14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
- 14.7.1. By Type
- 14.7.2. By Disease Indication
- 14.7.3. By Distribution Channel
- 14.7.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
- 15.3.1. Novartis AG
  - 15.3.1.1. Company Overview
  - 15.3.1.2. Product Portfolio
  - 15.3.1.3. SWOT Analysis
  - 15.3.1.4. Financial Overview
  - 15.3.1.5. Strategic Overview
- 15.3.2. AbbVie Inc.
  - 15.3.2.1. Company Overview
  - 15.3.2.2. Product Portfolio
  - 15.3.2.3. SWOT Analysis
  - 15.3.2.4. Financial Overview
  - 15.3.2.5. Strategic Overview
- 15.3.3. Eli Lilly and Company
  - 15.3.3.1. Company Overview
  - 15.3.3.2. Product Portfolio
  - 15.3.3.3. SWOT Analysis
  - 15.3.3.4. Financial Overview
  - 15.3.3.5. Strategic Overview
- 15.3.4. F. Hoffmann-La Roche AG
  - 15.3.4.1. Company Overview
  - 15.3.4.2. Product Portfolio
  - 15.3.4.3. SWOT Analysis
  - 15.3.4.4. Financial Overview
  - 15.3.4.5. Strategic Overview
- 15.3.5. Regeneron Pharmaceuticals, Inc.
  - 15.3.5.1. Company Overview
  - 15.3.5.2. Product Portfolio
  - 15.3.5.3. SWOT Analysis
  - 15.3.5.4. Financial Overview
  - 15.3.5.5. Strategic Overview
- 15.3.6. Johnson & Johnson
  - 15.3.6.1. Company Overview
  - 15.3.6.2. Product Portfolio
  - 15.3.6.3. SWOT Analysis
  - 15.3.6.4. Financial Overview
  - 15.3.6.5. Strategic Overview
- 15.3.7. AstraZeneca plc
  - 15.3.7.1. Company Overview
  - 15.3.7.2. Product Portfolio
  - 15.3.7.3. SWOT Analysis
  - 15.3.7.4. Financial Overview
  - 15.3.7.5. Strategic Overview
- 15.3.8. Bausch Health
  - 15.3.8.1. Company Overview
  - 15.3.8.2. Product Portfolio
  - 15.3.8.3. SWOT Analysis
  - 15.3.8.4. Financial Overview
  - 15.3.8.5. Strategic Overview
- 15.3.9. GSK plc
  - 15.3.9.1. Company Overview
  - 15.3.9.2. Product Portfolio
  - 15.3.9.3. SWOT Analysis
  - 15.3.9.4. Financial Overview
  - 15.3.9.5. Strategic Overview
- 15.3.10. Teva Pharmaceutical Industries Ltd.
  - 15.3.10.1. Company Overview
  - 15.3.10.2. Product Portfolio
  - 15.3.10.3. SWOT Analysis
  - 15.3.10.4. Financial Overview
  - 15.3.10.5. Strategic Overview
- 15.3.11. Sanofi S.A.
  - 15.3.11.1. Company Overview
  - 15.3.11.2. Product Portfolio
  - 15.3.11.3. SWOT Analysis
  - 15.3.11.4. Financial Overview
  - 15.3.11.5. Strategic Overview
- 15.3.12. Sun Pharmaceutical Industries Ltd.
  - 15.3.12.1. Company Overview
  - 15.3.12.2. Product Portfolio
  - 15.3.12.3. SWOT Analysis
  - 15.3.12.4. Financial Overview
  - 15.3.12.5. Strategic Overview

インターロイキン市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Interleukins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

インターロイキン市場- 調査範囲

目次

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：市場

第4章市場概要

第5章主要洞察

第6章世界の市場分析と予測：タイプ別

第7章世界の市場分析と予測：適応疾患別

第8章世界の市場分析と予測：流通チャネル別

第9章世界の市場分析と予測：地域別

第10章北米の市場分析と予測

第11章欧州の市場分析と予測

第12章アジア太平洋地域の市場分析と予測

第13章ラテンアメリカの市場分析と予測

第14章中東・アフリカの市場分析と予測

第15章競合情勢

List of Tables

List of Figures

Interleukins Market - Scope of Report

Key Questions Answered in Global interleukins Market Report:

Interleukins Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Interleukins Market

4. Market Overview

5. Key Insights

6. Global Interleukins Market Analysis and Forecast, by Type

7. Global Interleukins Market Analysis and Forecast, by Disease Indication

8. Global Interleukins Market Analysis and Forecast, by Distribution Channel

9. Global Interleukins Market Analysis and Forecast, by Region

10. North America Interleukins Market Analysis and Forecast

11. Europe Interleukins Market Analysis and Forecast

12. Asia Pacific Interleukins Market Analysis and Forecast

13. Latin America Interleukins Market Analysis and Forecast

14. Middle East & Africa Interleukins Market Analysis and Forecast

15. Competition Landscape

インターロイキン市場：世界の産業分析、規模、シェア、成長、動向、2024-2034年予測

Interleukins Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

インターロイキン市場- 調査範囲

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：市場

第4章 市場概要

第5章 主要洞察

第6章 世界の市場分析と予測：タイプ別

第7章 世界の市場分析と予測：適応疾患別

第8章 世界の市場分析と予測：流通チャネル別

第9章 世界の市場分析と予測：地域別

第10章 北米の市場分析と予測

第11章 欧州の市場分析と予測

第12章 アジア太平洋地域の市場分析と予測

第13章 ラテンアメリカの市場分析と予測

第14章 中東・アフリカの市場分析と予測

第15章 競合情勢

List of Tables

List of Figures

Interleukins Market - Scope of Report

Key Questions Answered in Global interleukins Market Report:

Interleukins Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Interleukins Market

4. Market Overview

5. Key Insights

6. Global Interleukins Market Analysis and Forecast, by Type

7. Global Interleukins Market Analysis and Forecast, by Disease Indication

8. Global Interleukins Market Analysis and Forecast, by Distribution Channel

9. Global Interleukins Market Analysis and Forecast, by Region

10. North America Interleukins Market Analysis and Forecast

11. Europe Interleukins Market Analysis and Forecast

12. Asia Pacific Interleukins Market Analysis and Forecast

13. Latin America Interleukins Market Analysis and Forecast

14. Middle East & Africa Interleukins Market Analysis and Forecast

15. Competition Landscape

第1章序文

第2章前提条件と調査手法

第3章エグゼクティブサマリー：市場

第4章市場概要

第5章主要洞察

第6章世界の市場分析と予測：タイプ別

第7章世界の市場分析と予測：適応疾患別

第8章世界の市場分析と予測：流通チャネル別

第9章世界の市場分析と予測：地域別

第10章北米の市場分析と予測

第11章欧州の市場分析と予測

第12章アジア太平洋地域の市場分析と予測

第13章ラテンアメリカの市場分析と予測

第14章中東・アフリカの市場分析と予測

第15章競合情勢